Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Developments in the molecular biology of DYT1 dystonia

Identifieur interne : 000952 ( PascalFrancis/Curation ); précédent : 000951; suivant : 000953

Developments in the molecular biology of DYT1 dystonia

Auteurs : Ruth H. Walker [États-Unis] ; P. Shashidharan [États-Unis]

Source :

RBID : Pascal:04-0095344

Descripteurs français

English descriptors

Abstract

The identification of a mutation of the DYTI gene as a cause of inherited dystonia has led to many insights regarding the genetics of this disorder. In addition, there is a rapidly expanding list of inherited dystonia syndromes, the genes for some of which have been identified or localized. The DYTI mutation has been found in a variety of ethnic groups, and it may result in a range of phenotypes. To date, studies of torsinA, the protein product of the DYTI gene, have not revealed its function, although its widespread distribution throughout the central nervous system suggests a universal role. TorsinA has structural homology to heat shock and chaperone proteins. Evidence from studies in cell cultures and Caenorhabditis elegans, and the presence of torsinA in inclusion bodies in several neurodegenerative diseases may be indicative of function of this nature. Preliminary studies in humans with DYTI dystonia and in DYTI transgenic mice suggest disruption of the dopaminergic nigrostriatal system. A functional interference with neuronal signal processing induced by mutation of torsinA is consistent with current hypotheses regarding impairment of the center-surround mechanism in the striatum.
pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 18
A06       @2 10
A08 01  1  ENG  @1 Developments in the molecular biology of DYT1 dystonia
A11 01  1    @1 WALKER (Ruth H.)
A11 02  1    @1 SHASHIDHARAN (P.)
A14 01      @1 Department of Neurology, Veterans Affairs Medical Center @2 Bronx, New York @3 USA @Z 1 aut.
A14 02      @1 Department of Neurology, Mount Sinai School of Medicine @2 New York, New York @3 USA @Z 1 aut. @Z 2 aut.
A20       @1 1102-1107
A21       @1 2003
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000113383090010
A44       @0 0000 @1 © 2004 INIST-CNRS. All rights reserved.
A45       @0 76 ref.
A47 01  1    @0 04-0095344
A60       @1 P
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 The identification of a mutation of the DYTI gene as a cause of inherited dystonia has led to many insights regarding the genetics of this disorder. In addition, there is a rapidly expanding list of inherited dystonia syndromes, the genes for some of which have been identified or localized. The DYTI mutation has been found in a variety of ethnic groups, and it may result in a range of phenotypes. To date, studies of torsinA, the protein product of the DYTI gene, have not revealed its function, although its widespread distribution throughout the central nervous system suggests a universal role. TorsinA has structural homology to heat shock and chaperone proteins. Evidence from studies in cell cultures and Caenorhabditis elegans, and the presence of torsinA in inclusion bodies in several neurodegenerative diseases may be indicative of function of this nature. Preliminary studies in humans with DYTI dystonia and in DYTI transgenic mice suggest disruption of the dopaminergic nigrostriatal system. A functional interference with neuronal signal processing induced by mutation of torsinA is consistent with current hypotheses regarding impairment of the center-surround mechanism in the striatum.
C02 01  X    @0 002B17G
C03 01  X  FRE  @0 Dystonie @5 01
C03 01  X  ENG  @0 Dystonia @5 01
C03 01  X  SPA  @0 Distonía @5 01
C03 02  X  FRE  @0 Mutation @5 04
C03 02  X  ENG  @0 Mutation @5 04
C03 02  X  SPA  @0 Mutación @5 04
C03 03  X  FRE  @0 Immunohistochimie @5 07
C03 03  X  ENG  @0 Immunohistochemistry @5 07
C03 03  X  SPA  @0 Inmunohistoquímica @5 07
C03 04  X  FRE  @0 Pénétrance génique @5 10
C03 04  X  ENG  @0 Gene penetrance @5 10
C03 04  X  SPA  @0 Penetrancia génica @5 10
C03 05  X  FRE  @0 Biologie moléculaire @5 17
C03 05  X  ENG  @0 Molecular biology @5 17
C03 05  X  SPA  @0 Biología molecular @5 17
C03 06  X  FRE  @0 Déterminisme génétique @5 18
C03 06  X  ENG  @0 Genetic determinism @5 18
C03 06  X  SPA  @0 Determinismo genético @5 18
C03 07  X  FRE  @0 Homme @5 20
C03 07  X  ENG  @0 Human @5 20
C03 07  X  SPA  @0 Hombre @5 20
C03 08  X  FRE  @0 Souris @5 21
C03 08  X  ENG  @0 Mouse @5 21
C03 08  X  SPA  @0 Ratón @5 21
C03 09  X  FRE  @0 Animal transgénique @5 22
C03 09  X  ENG  @0 Transgenic animal @5 22
C03 09  X  SPA  @0 Animal transgénico @5 22
C03 10  X  FRE  @0 Gène DYT1 @4 INC @5 86
C03 11  X  FRE  @0 TorsinA @4 INC @5 87
C07 01  X  FRE  @0 Rodentia @2 NS
C07 01  X  ENG  @0 Rodentia @2 NS
C07 01  X  SPA  @0 Rodentia @2 NS
C07 02  X  FRE  @0 Mammalia @2 NS
C07 02  X  ENG  @0 Mammalia @2 NS
C07 02  X  SPA  @0 Mammalia @2 NS
C07 03  X  FRE  @0 Vertebrata @2 NS
C07 03  X  ENG  @0 Vertebrata @2 NS
C07 03  X  SPA  @0 Vertebrata @2 NS
C07 04  X  FRE  @0 Muscle strié pathologie @5 37
C07 04  X  ENG  @0 Striated muscle disease @5 37
C07 04  X  SPA  @0 Músculo estriado patología @5 37
C07 05  X  FRE  @0 Système nerveux pathologie @5 38
C07 05  X  ENG  @0 Nervous system diseases @5 38
C07 05  X  SPA  @0 Sistema nervioso patología @5 38
C07 06  X  FRE  @0 Trouble neurologique @5 39
C07 06  X  ENG  @0 Neurological disorder @5 39
C07 06  X  SPA  @0 Trastorno neurológico @5 39
C07 07  X  FRE  @0 Mouvement involontaire @5 40
C07 07  X  ENG  @0 Involuntary movement @5 40
C07 07  X  SPA  @0 Movimiento involuntario @5 40
C07 08  X  FRE  @0 Extrapyramidal syndrome @5 41
C07 08  X  ENG  @0 Extrapyramidal syndrome @5 41
C07 08  X  SPA  @0 Extrapiramidal síndrome @5 41
C07 09  X  FRE  @0 Maladie héréditaire @5 42
C07 09  X  ENG  @0 Genetic disease @5 42
C07 09  X  SPA  @0 Enfermedad hereditaria @5 42
C07 10  X  FRE  @0 Anatomopathologie @5 53
C07 10  X  ENG  @0 Anatomic pathology @5 53
C07 10  X  SPA  @0 Anatomía patológica @5 53
N21       @1 061
N82       @1 PSI

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:04-0095344

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Developments in the molecular biology of DYT1 dystonia</title>
<author>
<name sortKey="Walker, Ruth H" sort="Walker, Ruth H" uniqKey="Walker R" first="Ruth H." last="Walker">Ruth H. Walker</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Veterans Affairs Medical Center</s1>
<s2>Bronx, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Neurology, Mount Sinai School of Medicine</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Shashidharan, P" sort="Shashidharan, P" uniqKey="Shashidharan P" first="P." last="Shashidharan">P. Shashidharan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Neurology, Mount Sinai School of Medicine</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">04-0095344</idno>
<date when="2003">2003</date>
<idno type="stanalyst">PASCAL 04-0095344 INIST</idno>
<idno type="RBID">Pascal:04-0095344</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002369</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000952</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Developments in the molecular biology of DYT1 dystonia</title>
<author>
<name sortKey="Walker, Ruth H" sort="Walker, Ruth H" uniqKey="Walker R" first="Ruth H." last="Walker">Ruth H. Walker</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Veterans Affairs Medical Center</s1>
<s2>Bronx, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Neurology, Mount Sinai School of Medicine</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Shashidharan, P" sort="Shashidharan, P" uniqKey="Shashidharan P" first="P." last="Shashidharan">P. Shashidharan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Neurology, Mount Sinai School of Medicine</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2003">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Dystonia</term>
<term>Gene penetrance</term>
<term>Genetic determinism</term>
<term>Human</term>
<term>Immunohistochemistry</term>
<term>Molecular biology</term>
<term>Mouse</term>
<term>Mutation</term>
<term>Transgenic animal</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Dystonie</term>
<term>Mutation</term>
<term>Immunohistochimie</term>
<term>Pénétrance génique</term>
<term>Biologie moléculaire</term>
<term>Déterminisme génétique</term>
<term>Homme</term>
<term>Souris</term>
<term>Animal transgénique</term>
<term>Gène DYT1</term>
<term>TorsinA</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
<term>Animal transgénique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The identification of a mutation of the DYTI gene as a cause of inherited dystonia has led to many insights regarding the genetics of this disorder. In addition, there is a rapidly expanding list of inherited dystonia syndromes, the genes for some of which have been identified or localized. The DYTI mutation has been found in a variety of ethnic groups, and it may result in a range of phenotypes. To date, studies of torsinA, the protein product of the DYTI gene, have not revealed its function, although its widespread distribution throughout the central nervous system suggests a universal role. TorsinA has structural homology to heat shock and chaperone proteins. Evidence from studies in cell cultures and Caenorhabditis elegans, and the presence of torsinA in inclusion bodies in several neurodegenerative diseases may be indicative of function of this nature. Preliminary studies in humans with DYTI dystonia and in DYTI transgenic mice suggest disruption of the dopaminergic nigrostriatal system. A functional interference with neuronal signal processing induced by mutation of torsinA is consistent with current hypotheses regarding impairment of the center-surround mechanism in the striatum.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>18</s2>
</fA05>
<fA06>
<s2>10</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Developments in the molecular biology of DYT1 dystonia</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>WALKER (Ruth H.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>SHASHIDHARAN (P.)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Neurology, Veterans Affairs Medical Center</s1>
<s2>Bronx, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Department of Neurology, Mount Sinai School of Medicine</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA20>
<s1>1102-1107</s1>
</fA20>
<fA21>
<s1>2003</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000113383090010</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2004 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>76 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>04-0095344</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>The identification of a mutation of the DYTI gene as a cause of inherited dystonia has led to many insights regarding the genetics of this disorder. In addition, there is a rapidly expanding list of inherited dystonia syndromes, the genes for some of which have been identified or localized. The DYTI mutation has been found in a variety of ethnic groups, and it may result in a range of phenotypes. To date, studies of torsinA, the protein product of the DYTI gene, have not revealed its function, although its widespread distribution throughout the central nervous system suggests a universal role. TorsinA has structural homology to heat shock and chaperone proteins. Evidence from studies in cell cultures and Caenorhabditis elegans, and the presence of torsinA in inclusion bodies in several neurodegenerative diseases may be indicative of function of this nature. Preliminary studies in humans with DYTI dystonia and in DYTI transgenic mice suggest disruption of the dopaminergic nigrostriatal system. A functional interference with neuronal signal processing induced by mutation of torsinA is consistent with current hypotheses regarding impairment of the center-surround mechanism in the striatum.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Dystonie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Dystonia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Distonía</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Mutation</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Mutation</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Mutación</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Immunohistochimie</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Immunohistochemistry</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Inmunohistoquímica</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Pénétrance génique</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Gene penetrance</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Penetrancia génica</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Biologie moléculaire</s0>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Molecular biology</s0>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Biología molecular</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Déterminisme génétique</s0>
<s5>18</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Genetic determinism</s0>
<s5>18</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Determinismo genético</s0>
<s5>18</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Souris</s0>
<s5>21</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Mouse</s0>
<s5>21</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Ratón</s0>
<s5>21</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Animal transgénique</s0>
<s5>22</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Transgenic animal</s0>
<s5>22</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Animal transgénico</s0>
<s5>22</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Gène DYT1</s0>
<s4>INC</s4>
<s5>86</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>TorsinA</s0>
<s4>INC</s4>
<s5>87</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Muscle strié pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Striated muscle disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Músculo estriado patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Trouble neurologique</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Neurological disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Trastorno neurológico</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Mouvement involontaire</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Involuntary movement</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Movimiento involuntario</s0>
<s5>40</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>41</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>41</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>41</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE">
<s0>Maladie héréditaire</s0>
<s5>42</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG">
<s0>Genetic disease</s0>
<s5>42</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA">
<s0>Enfermedad hereditaria</s0>
<s5>42</s5>
</fC07>
<fC07 i1="10" i2="X" l="FRE">
<s0>Anatomopathologie</s0>
<s5>53</s5>
</fC07>
<fC07 i1="10" i2="X" l="ENG">
<s0>Anatomic pathology</s0>
<s5>53</s5>
</fC07>
<fC07 i1="10" i2="X" l="SPA">
<s0>Anatomía patológica</s0>
<s5>53</s5>
</fC07>
<fN21>
<s1>061</s1>
</fN21>
<fN82>
<s1>PSI</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000952 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000952 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:04-0095344
   |texte=   Developments in the molecular biology of DYT1 dystonia
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024